enspryng

Generic: satralizumab

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name enspryng
Generic Name satralizumab
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

satralizumab 120 mg/mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-007
Product ID 50242-007_934d1456-ebad-46b5-8f09-ff9aed5e4e88
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761149
Listing Expiration 2026-12-31
Marketing Start 2020-08-14

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242007
Hyphenated Format 50242-007

Supplemental Identifiers

RxCUI
2391555 2391560
UNII
YB18NF020M

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name enspryng (source: ndc)
Generic Name satralizumab (source: ndc)
Application Number BLA761149 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 120 mg/mL
source: ndc
Packaging
  • 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 SYRINGE, PLASTIC
  • 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-86) / 1 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (2)

50242-007-01 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 SYRINGE, PLASTIC 50242-007-86 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-86) / 1 mL in 1 SYRINGE, PLASTIC

Ingredients (1)

satralizumab (120 mg/mL)

Linked Drug Pages (1)

Enspryng ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "934d1456-ebad-46b5-8f09-ff9aed5e4e88", "openfda": {"unii": ["YB18NF020M"], "rxcui": ["2391555", "2391560"], "spl_set_id": ["64c156a4-9bad-4d45-a294-0733c141f47b"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01)  / 1 mL in 1 SYRINGE, PLASTIC", "package_ndc": "50242-007-01", "marketing_start_date": "20200814"}, {"sample": true, "description": "1 SYRINGE, PLASTIC in 1 CARTON (50242-007-86)  / 1 mL in 1 SYRINGE, PLASTIC", "package_ndc": "50242-007-86", "marketing_start_date": "20210813"}], "brand_name": "Enspryng", "product_id": "50242-007_934d1456-ebad-46b5-8f09-ff9aed5e4e88", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "50242-007", "generic_name": "Satralizumab", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Enspryng", "active_ingredients": [{"name": "SATRALIZUMAB", "strength": "120 mg/mL"}], "application_number": "BLA761149", "marketing_category": "BLA", "marketing_start_date": "20200814", "listing_expiration_date": "20261231"}